VI
VYGR icon

Vestcor Inc’s Voyager Therapeutics VYGR Stock Holding History

Vestcor Inc’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,874
Closed -$90K – 1299
2025
Q4 		$90K Hold
22,874
– – ﹤0.01% 1070
2025
Q3 		$107K Hold
22,874
– – ﹤0.01% 1083
2025
Q2 		$71K Hold
22,874
– – ﹤0.01% 1085
2025
Q1 		$77K Hold
22,874
– – ﹤0.01% 1081
2024
Q4 		$130K Hold
22,874
– – ﹤0.01% 1064
2024
Q3 		$134K Hold
22,874
– – ﹤0.01% 1022
2024
Q2 		$181K Hold
22,874
– – 0.01% 967
2024
Q1 		$213K Sell
22,874
-15,254
-40% -$129K 0.01% 947
2023
Q4 		$322K Hold
38,128
– – 0.01% 820
2023
Q3 		$295K Hold
38,128
– – 0.01% 834
2023
Q2 		$437K Buy
+38,128
New +$394K 0.02% 635

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vestcor Inc's VYGR Position: Q1 2026 in Review

Vestcor Inc sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 22,874 shares — an estimated $90K sold.

Vestcor Inc first reported a position in VYGR in Q2 2023 and held it in 11 quarters. The position peaked at $437K in Q2 2023. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Vestcor Inc reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Vestcor Inc sold 22,874 Voyager Therapeutics shares in Q1 2026, an estimated $90K.
  • Vestcor Inc first reported a position in Voyager Therapeutics in Q2 2023 and held it in 11 quarters.
  • Vestcor Inc's Voyager Therapeutics position peaked at $437K in Q2 2023.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.